Skip to main content
Clinical Trials/JPRN-UMIN000033257
JPRN-UMIN000033257RecruitingPhase 2

A positive clinical trial of carbon-ion radiotherapy for peripherally located stage-I non small cell lung cancer. - Carbon-ion radiotherapy for peripherally located stage-I non small cell lung cancer.(iROCK-1703LU)

Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization0 sites162 target enrollmentStarted: July 3, 2018Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Sponsor
Enrollment
162

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1) Severe comorbidities including infection and mental disorders 2) Interstitial pneumonitis on CT images 3) Patient with active double cancer, active and untreated double cancer, except for intraepithelial carcinoma, intramucinous carcinoma or malignancy controlled for a long-term 4) Interstitial pneumonitis on CT images 5) Pregnant women, women who may become pregnant 6) When it is not possible to confirm the intention of the person by the decline of cognitive function 7) Medically or psychologically unsuitable conditions

Investigators

Sponsor
Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization

Similar Trials